The clinical trial supplies market size has grown strongly in recent years. It will grow from $2.86 billion in 2025 to $3.1 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increase in global clinical trial activity, expansion of multicenter trial designs, growth of biologics and specialty drugs, rising outsourcing to CROs, development of cold-chain logistics infrastructure.
The clinical trial supplies market size is expected to see strong growth in the next few years. It will grow to $4.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing complexity of clinical trial protocols, expansion of decentralized and virtual trials, rising focus on patient-centric trial models, growing investments in digital trial management tools, increasing regulatory scrutiny across regions. Major trends in the forecast period include increasing adoption of integrated supply chain platforms, rising use of temperature-controlled logistics solutions, growing demand for end-to-end trial visibility, expansion of adaptive packaging and labeling services, enhanced focus on compliance and traceability.
The clinical trial supplies market is poised for substantial growth, driven by the escalating number of registered clinical trials. These trials, essential for assessing the safety and efficacy of new medical treatments, interventions, and diagnostic procedures, rely on a range of supplies, including pharmaceuticals and medical devices. To illustrate, in May 2023, ClinicalTrials.gov reported a notable increase, with 437,533 registered clinical trials compared to 399,499 in 2022 across the United States and 221 countries. This surge in clinical trial registrations is a key factor fueling the expansion of the clinical trial supplies market, crucial for ensuring successful trials, accurate data collection, and patient safety.
Leading companies in this market are embracing innovative technologies to revolutionize healthcare decision-making, drug development, and patient care. This strategic move involves harnessing real-world data to generate evidence-based insights. As an illustration, in April 2023, Komodo Health, a US-based healthcare technology company, introduced MapEnhance - an integrated real-world evidence technology platform. This platform, incorporating a network of specialty data partners, provides customers with a comprehensive perspective on clinical events and patient populations. MapEnhance includes precision molecular diagnostics, standard laboratory diagnostics, and electronic medical records, offering unparalleled insights for various therapeutic areas and hospital settings.
In May 2024, Myonex, a pharmaceutical company based in the US, acquired Creapharm’s pharmaceutical services for an undisclosed amount. Following this acquisition, Creapharm's capabilities in clinical packaging, distribution, commercial packaging, and bioservices will operate under the name Creapharm, a Myonex company. This merger enhances flexibility and strengthens service offerings for pharmaceutical and biotech companies at both clinical and commercial stages, including those involved with Advanced Therapies. Creapharm is a manufacturer of clinical trial supplies based in France.
Major companies operating in the clinical trial supplies market are Thermo Fisher Scientific Inc., IQVIA, Eurofins Scientific SE, Parexel International Corporation, ICON PLC, Catalent Inc., Intertek Group PLC, Recipharm AB, World Courier, Almac Group Ltd., Piramal Pharma Solutions, Clinigen Group PLC, Movianto GmbH, Marken Limited, PCI Pharma Services, Rubicon Research Private Limited, Bionical Ltd., Durbin PLC, SIRO Clinpharm Pvt. Ltd., Biocair International Ltd., Ancillare LP., Myonex, Klifo A/S, Alium Medical Limited, ADAllen Pharma, Sharp Services LLC.
North America was the largest region in the clinical trial supplies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial supplies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical trial supplies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the clinical trial supplies market by increasing costs of imported packaging materials, temperature-controlled containers, labeling components, and logistics equipment used across global trial supply chains. Pharmaceutical sponsors and CROs in North America and Europe are most affected due to reliance on cross-border sourcing, while Asia-Pacific faces cost pressure on export-oriented supply services. These tariffs are extending trial timelines and increasing operational budgets. However, they are also accelerating regional supply hub development, local packaging capabilities, and resilient sourcing strategies.
The clinical trial supplies market research report is one of a series of new reports that provides clinical trial supplies market statistics, including clinical trial supplies industry global market size, regional shares, competitors with a clinical trial supplies market share, detailed clinical trial supplies market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial supplies industry. This clinical trial supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Clinical trial supplies encompass materials, products, and equipment pivotal for the smooth conduct of clinical trials. They are instrumental in facilitating testing and evaluation processes.
Essential services related to clinical trial supplies involve logistics and distribution, storage and retention, supply chain management, packaging, labeling, blinding manufacturing, and comparator sourcing. Logistics and distribution manage the movement of trial supplies from manufacturing facilities to trial sites, ensuring prompt availability and efficient delivery. These supplies are crucial across various clinical phases (Phase I to Phase IV) for treating conditions such as oncology, CNS disorders, cardiovascular ailments, infectious diseases, metabolic disorders, among others. End users include pharmaceutical and biotech companies, contract research organizations (CROs), and medical device firms.
The clinical trial supplies market consists of revenues earned by entities by providing quality control, regulatory compliance, and return and destruction management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial supplies market also includes sales of investigational products, comparator products, and clinical trial kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The clinical trial supplies market size is expected to see strong growth in the next few years. It will grow to $4.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing complexity of clinical trial protocols, expansion of decentralized and virtual trials, rising focus on patient-centric trial models, growing investments in digital trial management tools, increasing regulatory scrutiny across regions. Major trends in the forecast period include increasing adoption of integrated supply chain platforms, rising use of temperature-controlled logistics solutions, growing demand for end-to-end trial visibility, expansion of adaptive packaging and labeling services, enhanced focus on compliance and traceability.
The clinical trial supplies market is poised for substantial growth, driven by the escalating number of registered clinical trials. These trials, essential for assessing the safety and efficacy of new medical treatments, interventions, and diagnostic procedures, rely on a range of supplies, including pharmaceuticals and medical devices. To illustrate, in May 2023, ClinicalTrials.gov reported a notable increase, with 437,533 registered clinical trials compared to 399,499 in 2022 across the United States and 221 countries. This surge in clinical trial registrations is a key factor fueling the expansion of the clinical trial supplies market, crucial for ensuring successful trials, accurate data collection, and patient safety.
Leading companies in this market are embracing innovative technologies to revolutionize healthcare decision-making, drug development, and patient care. This strategic move involves harnessing real-world data to generate evidence-based insights. As an illustration, in April 2023, Komodo Health, a US-based healthcare technology company, introduced MapEnhance - an integrated real-world evidence technology platform. This platform, incorporating a network of specialty data partners, provides customers with a comprehensive perspective on clinical events and patient populations. MapEnhance includes precision molecular diagnostics, standard laboratory diagnostics, and electronic medical records, offering unparalleled insights for various therapeutic areas and hospital settings.
In May 2024, Myonex, a pharmaceutical company based in the US, acquired Creapharm’s pharmaceutical services for an undisclosed amount. Following this acquisition, Creapharm's capabilities in clinical packaging, distribution, commercial packaging, and bioservices will operate under the name Creapharm, a Myonex company. This merger enhances flexibility and strengthens service offerings for pharmaceutical and biotech companies at both clinical and commercial stages, including those involved with Advanced Therapies. Creapharm is a manufacturer of clinical trial supplies based in France.
Major companies operating in the clinical trial supplies market are Thermo Fisher Scientific Inc., IQVIA, Eurofins Scientific SE, Parexel International Corporation, ICON PLC, Catalent Inc., Intertek Group PLC, Recipharm AB, World Courier, Almac Group Ltd., Piramal Pharma Solutions, Clinigen Group PLC, Movianto GmbH, Marken Limited, PCI Pharma Services, Rubicon Research Private Limited, Bionical Ltd., Durbin PLC, SIRO Clinpharm Pvt. Ltd., Biocair International Ltd., Ancillare LP., Myonex, Klifo A/S, Alium Medical Limited, ADAllen Pharma, Sharp Services LLC.
North America was the largest region in the clinical trial supplies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial supplies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical trial supplies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the clinical trial supplies market by increasing costs of imported packaging materials, temperature-controlled containers, labeling components, and logistics equipment used across global trial supply chains. Pharmaceutical sponsors and CROs in North America and Europe are most affected due to reliance on cross-border sourcing, while Asia-Pacific faces cost pressure on export-oriented supply services. These tariffs are extending trial timelines and increasing operational budgets. However, they are also accelerating regional supply hub development, local packaging capabilities, and resilient sourcing strategies.
The clinical trial supplies market research report is one of a series of new reports that provides clinical trial supplies market statistics, including clinical trial supplies industry global market size, regional shares, competitors with a clinical trial supplies market share, detailed clinical trial supplies market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial supplies industry. This clinical trial supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Clinical trial supplies encompass materials, products, and equipment pivotal for the smooth conduct of clinical trials. They are instrumental in facilitating testing and evaluation processes.
Essential services related to clinical trial supplies involve logistics and distribution, storage and retention, supply chain management, packaging, labeling, blinding manufacturing, and comparator sourcing. Logistics and distribution manage the movement of trial supplies from manufacturing facilities to trial sites, ensuring prompt availability and efficient delivery. These supplies are crucial across various clinical phases (Phase I to Phase IV) for treating conditions such as oncology, CNS disorders, cardiovascular ailments, infectious diseases, metabolic disorders, among others. End users include pharmaceutical and biotech companies, contract research organizations (CROs), and medical device firms.
The clinical trial supplies market consists of revenues earned by entities by providing quality control, regulatory compliance, and return and destruction management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial supplies market also includes sales of investigational products, comparator products, and clinical trial kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Clinical Trial Supplies Market Characteristics
3. Clinical Trial Supplies Market Supply Chain Analysis
4. Global Clinical Trial Supplies Market Trends and Strategies
5. Clinical Trial Supplies Market Analysis of End Use Industries
7. Global Clinical Trial Supplies Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Clinical Trial Supplies Total Addressable Market (TAM) Analysis for the Market
9. Clinical Trial Supplies Market Segmentation
10. Clinical Trial Supplies Market Regional and Country Analysis
11. Asia-Pacific Clinical Trial Supplies Market
12. China Clinical Trial Supplies Market
13. India Clinical Trial Supplies Market
14. Japan Clinical Trial Supplies Market
15. Australia Clinical Trial Supplies Market
16. Indonesia Clinical Trial Supplies Market
17. South Korea Clinical Trial Supplies Market
18. Taiwan Clinical Trial Supplies Market
19. South East Asia Clinical Trial Supplies Market
20. Western Europe Clinical Trial Supplies Market
21. UK Clinical Trial Supplies Market
22. Germany Clinical Trial Supplies Market
23. France Clinical Trial Supplies Market
24. Italy Clinical Trial Supplies Market
25. Spain Clinical Trial Supplies Market
26. Eastern Europe Clinical Trial Supplies Market
27. Russia Clinical Trial Supplies Market
28. North America Clinical Trial Supplies Market
29. USA Clinical Trial Supplies Market
30. Canada Clinical Trial Supplies Market
31. South America Clinical Trial Supplies Market
32. Brazil Clinical Trial Supplies Market
33. Middle East Clinical Trial Supplies Market
34. Africa Clinical Trial Supplies Market
36. Clinical Trial Supplies Market Competitive Landscape and Company Profiles
37. Clinical Trial Supplies Market Other Major and Innovative Companies
40. Clinical Trial Supplies Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Clinical Trial Supplies Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses clinical trial supplies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for clinical trial supplies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical trial supplies market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Services: Logistics And Distribution; Storage And Retention; Supply Chain Management; Packaging, Labeling, And Blinding; Comparator Sourcing2) By Clinical Phases: Phase I; Phase II; Phase III; Phase IV
3) By Therapeutic Use: Oncology; Central Nervous System (CNS); Cardiovascular; Infectious Disease; Metabolic Disorders; Other Therapeutic Uses
4) By End User: Pharmaceutical And Biotech companies; Contract Research Organization (CRO)
Subsegments:
1) By Logistics And Distribution: Transportation; Inventory Management; Temperature-Controlled Shipping; Customs Clearance2) By Storage And Retention: Short-term Storage; Long-term Storage; Controlled Environment Storage
3) By Supply Chain Management: Planning And Forecasting; Supplier Management; Risk Management; Compliance Management
4) By Packaging, Labeling, And Blinding: Primary Packaging; Secondary Packaging; Label Design And Printing; Blinding Techniques
5) By Comparator Sourcing: Sourcing Of Reference Products; Quality Control And Assurance; Regulatory Compliance For Comparators
Companies Mentioned: Thermo Fisher Scientific Inc.; IQVIA; Eurofins Scientific SE; Parexel International Corporation; ICON PLC; Catalent Inc.; Intertek Group PLC; Recipharm AB; World Courier; Almac Group Ltd.; Piramal Pharma Solutions; Clinigen Group PLC; Movianto GmbH; Marken Limited; PCI Pharma Services; Rubicon Research Private Limited; Bionical Ltd.; Durbin PLC; SIRO Clinpharm Pvt. Ltd.; Biocair International Ltd.; Ancillare LP.; Myonex; Klifo A/S; Alium Medical Limited; ADAllen Pharma; Sharp Services LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Clinical Trial Supplies market report include:- Thermo Fisher Scientific Inc.
- IQVIA
- Eurofins Scientific SE
- Parexel International Corporation
- ICON PLC
- Catalent Inc.
- Intertek Group PLC
- Recipharm AB
- World Courier
- Almac Group Ltd.
- Piramal Pharma Solutions
- Clinigen Group PLC
- Movianto GmbH
- Marken Limited
- PCI Pharma Services
- Rubicon Research Private Limited
- Bionical Ltd.
- Durbin PLC
- SIRO Clinpharm Pvt. Ltd.
- Biocair International Ltd.
- Ancillare LP.
- Myonex
- Klifo A/S
- Alium Medical Limited
- ADAllen Pharma
- Sharp Services LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.1 Billion |
| Forecasted Market Value ( USD | $ 4.33 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
